Literature DB >> 19915223

Cangrelor - a champion lost in translation?

Adnan Kastrati, Gjin Ndrepepa.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19915223     DOI: 10.1056/NEJMe0910677

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  [Periinterventional antiplatelet therapy: from bench to bedside].

Authors:  D Braun; C Schulz; D Sibbing; S Massberg
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

Review 2.  New antithrombotic agents--insights from clinical trials.

Authors:  Jeremy S Paikin; John W Eikelboom; John A Cairns; Jack Hirsh
Journal:  Nat Rev Cardiol       Date:  2010-06-29       Impact factor: 32.419

3.  FoxO1 target Gpr17 activates AgRP neurons to regulate food intake.

Authors:  Hongxia Ren; Ian J Orozco; Ya Su; Shigetomo Suyama; Roger Gutiérrez-Juárez; Tamas L Horvath; Sharon L Wardlaw; Leona Plum; Ottavio Arancio; Domenico Accili
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

Review 4.  Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review.

Authors:  Refai Showkathali; Arun Natarajan
Journal:  Curr Cardiol Rev       Date:  2012-08

5.  Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis.

Authors:  Yue Fei; Cheuk Kiu Lam; Bernard Man Yung Cheung
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

6.  Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial.

Authors:  Georg Gelbenegger; Juergen Grafeneder; Gloria M Gager; Jolanta M Siller-Matula; Michael Schwameis; Bernd Jilma; Christian Schoergenhofer
Journal:  Thromb J       Date:  2022-04-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.